Table 1 Histomorphometric analysis of new bone, connective tissue and residual graft during 4, 8 and 12 weeks.

From: Effects of strontium ions with potential antibacterial activity on in vivo bone regeneration

 

Gel-BG/Sr

Gel-BG

Control

NB (%)

4 weeks

11.71 ± 0.84a

7.1 ± 0.7b

4.2 ± 0.42c

8 weeks

30.2 ± 3.3a

21.02 ± 0.88b

14.15 ± 0.27c

12 weeks

49.1 ± 3.73a

33.88 ± 0.35b

17.32 ± 0.36c

RG (%)

4 weeks

60.68 ± 1.62a

69.8 ± 0.54b

0.00c

8 weeks

53.56 ± 1.64a

58.43 ± 1.41b

0.00c

12 weeks

41.50 ± 1.94a

51.34 ± 0.98b

0.00c

CT (%)

4 weeks

28.15 ± 0.73a

25.10 ± 0.3b

95.08 ± 0.21c

8 weeks

16.23 ± 0.41a

20.55 ± 0.68b

85.85 ± 0.56c

12 weeks

9.4 ± 0.18a

14.78 ± 0.09b

82.68 ± 0.38c

  1. Data are represented as mean ± SD. Different letters in each row show P < 0.001; a, b, c: significant difference with other groups at the same time; NB The percentage of New Bone, RG the percentage of Residual Graft, CT The percentage of Connective Tissue.